Finally, we discuss our current understanding of the crosstalk between mediators, with a special focus on TGF-β and chemokines, to provide insights into the integrated mechanisms underlying neutrophil recruitment to the tumor niche and suggest gaps in knowledge that need to be filled for the development of anti-cancer therapeutic interventions. Here, TGFB1 is linked to cancer.